top of page
MAXWELLIA CEO, ANNA MAXWELL HAS BEEN APPOINTED A FELLOW OF THE ROYAL PHARMACEUTICAL SOCIETY
WORLD PHARMACISTS DAY 2022:
PHARMACY IN ACTION FOR A HEALTHIER WORLD
MAXWELLIA CEO ANNA MAXWELL MEETS SECRETARY OF STATE,
LIZ TRUSS
PUBLIC CONSULTATION ANNOUNCED FOR MAXWELLIA’S SECOND WOMEN’S HEALTH PRODUCT
IAN ADAMSON JOINS MAXWELLIA AS STRATEGIC ADVISOR
MAXWELLIA UNVEILS BOLD £3M 360° SUPPORT CAMPAIGN TO DRIVE AWARENESS OF ITS CONTRACEPTIVE PILL LOVIMA
®
CHANNEL 4 VENTURES INVESTS IN MAXWELLIA – THE LEADING MEDICINES SWITCH COMPANY
APPOINTMENT OF
SARA AL-ATTBI AS
MEDICAL AFFAIRS PHARMACIST
GAME CHANGER
Anna Maxwell, the founder and CEO of Maxwellia, tells Breakthrough how her pioneering business will widen access to medicine.
WOMEN CAN BUY MAXWELLIA’S LOVIMA® CONTRACEPTIVE PILL FROM PHARMACIES WITHOUT A PRESCRIPTION FOR FIRST TIME IN UK HISTORY
Wider availability of desogestrel welcomed by UK’s leading women’s health organisations
MAXWELLIA MAKES ‘MOST EXCITING COMPANIES’ LIST IN NORTH WEST BUSINESS INSIDER MAGAZINE
MAXWELLIA SECURES £500K BRITISH GOVERNMENT BACKED FUTURE FUND INVESTMENT
PRAETURA LEADS SELF CARE FIRM INVESTMENT ROUND
PUBLIC CONSULTATION ANNOUNCED FOR MAXWELLIA’S FIRST WOMEN’S HEALTH PRODUCT
OUR CEO TALKS TO HBW INDUSTRY INSIGHT ABOUT MAXWELLIA’S TRANSITION INTO A CONSUMER HEALTHCARE COMPANY
BIOCITY FEATURE MAXWELLIA CEO ON IWD 2021 CHALLENGING ACCESS TO CONTRACEPTION
SPEARHEADING SHIFT TO SELF CARE WITH THREE PHARMACY PRODUCTS IN LAUNCH PIPELINE
Pharmacists at heart of nation's public health
APPOINTMENT OF PARESH BALDANIYA AS HEAD OF QUALITY & REGULATORY AFFAIRS
Paresh has a pharmacy background and a stellar track record
APPOINTMENT OF JACK GRIMSHAW AS FINANCE DIRECTOR
Jack brings to Maxwellia more than 10 years of finance experience across a range of industries
TOP MOVER AND SHAKER IN BIOBUSINESS 2019
Our CEO and founder, Anna Maxwell has been listed in the top 50 movers and shakers of 2019 by BioBusiness
BIOCITY INVESTS IN MAXWELLIA
Life science incubator and business collective BioCity has announced an investment in Alderley Park-based Maxwellia
POM TO P SWITCHES: WHAT MADE MALOFF PROTECT AND ELLAONE A SUCCESS?
C+D deputy editor Grace Lewis spoke to Anna Maxwell, CEO of Maxwellia, about what makes a successful POM to P change
MAXWELLIA MEETS THE HEALTH SECRETARY
Maxwellia had the opportunity to put the switch agenda on the radar of Matt Hancock, Secretary of State for Health and Social Care
THE POWER OF ALIGNING YOUR BUSINESS TO A GLOBAL GOAL
Maxwellia is mentioned in Forbes for aligning to Global Goal 3 Good Health
MAXWELLIA EXPANDS TEAM OF SWITCH EXPERTS AS IT BUILDS THE PRODUCT PIPELINE
Appointments will expedite conversion of prescription medicines to over the counter
UK IS FERTILE GROUND FOR SWITCHING
With the recent switch of Pfizer’s Viagra, the UK has shown itself to be an open and progressive market for prescription-to-OTC reclassification.
MAXWELLIA ANNOUNCES FUNDING TO ACCELERATE ITS MISSION FOR SELF CARE
Investment will expedite conversion of prescription medicines to over the counter
bottom of page